The Generic version of the COVID-19 Oral antiviral therapy candidate nirmatrelvir has been approved by the World Health Organization Prequalification of Medicines Program (WHO PQ), as stated by the Indian pharmaceutical company Hetero. This is the first prequalification for a generic form of PAXLOVID, an oral antiviral medicine manufactured by Pfizer and designated by the […]

The post WHO Authorizes PAXLOVID, The First Oral COVID-19 Generic first appeared on World Pharma Today.